Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Inverna Therapeutics ApS
APS
Active
CVR 45161641
Cortex Park 26E, 5230
Odense M
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 1 year old
— employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Inverna Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (2)
US
Ulrika Simone Spangsberg Petersen
Founder
Founder
2024
LL
Lise Lolle Holm
Founder
Founder
2024
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (3)
MA
Mads Aaboe Jensen
Board of Directors
Board of Directors
2024
PF
Pontus Fredrik Gunnar Klein
Board of Directors
Board of Directors
2024
PS
Poul Sørensen
Chairman
Chairman
2024
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Argobio SAS
Individual
50–66.65%
50–66.65%
2025
Brage Storstein Andresen
Individual
10–14.99%
10–14.99%
2025
SCIENCE VENTURES DENMARK A/S
Company
5–9.99%
5–9.99%
2024
Thomas Koed Doktor
Individual
5–9.99%
5–9.99%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Inverna Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
